Table 2.
Association between sociodemographic and clinical characteristics and deliberation preference (n = 328)
| Low deliberation preference (n = 86) | High deliberation preference (n = 242) | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|---|
| Characteristics | (mean ± SD) or median (P25, P75) or n (%) | (mean ± SD) or median (P25, P75) or n (%) | Crude OR (95% CI) | p value | Adjusted OR (95% CI) | p value |
| Age (year) | 56.99 ± 13.10 | 46.63 ± 13.15 | 0.938 (0.918–0.959) | <.001 | 0.942 (0.913–0.972) | <.001 |
| Gender | ||||||
| Female | 42 (12.8) | 116 (35.4) | Ref | |||
| Male | 44 (13.4) | 126 (38.4) | 1.037 (0.634–1.696) | .885 | ||
| Marital status | .117 | |||||
| Unmarried | 5 (1.5) | 25 (7.6) | Ref | |||
| Married | 73 (22.3) | 207 (63.1) | 0.567 (0.209–1.536) | .265 | ||
| Divorced or widowed | 8 (2.4) | 10 (3.0) | 0.252 (0.066–0.851) | .105 | ||
| Education level | <.001 | <.001 | ||||
| Primary school | 56 (17.1) | 36 (11.0) | Ref | Ref | ||
| Middle school | 26 (7.9) | 101 (30.8) | 6.043 (3.313–11.021) | <.001 | 4.233 (2.170–8.219) | <.001 |
| High school or college | 2 (0.6) | 63 (19.2) | 32.667 (7.443–143.362) | <.001 | 20.606 (4.300–98.739) | <.001 |
| Bachelor or above | 2 (0.6) | 42 (12.8) | 49.000 (11.281–212.831) | <.001 | 33.290 (7.282–152.195) | <.001 |
| Residence | ||||||
| Rural | 55 (16.8) | 99 (30.2) | Ref | Ref | ||
| Town or city | 31 (9.5) | 143 (43.5) | 2.563 (1.540–4.265) | <.001 | 0.827 (0.404–1.692) | .603 |
| Annual family income | ‐ | .001 | .779 | |||
| <50,000 RMB | 55 (16.8) | 99 (30.2) | Ref | Ref | ||
| 50,000–150,000 RMB | 27 (8.2) | 116 (35.4) | 2.387 (1.401–4.067) | .001 | 1.139 (0.565–2.293) | .716 |
| >150,000RMB | 4 (1.2) | 27 (8.2) | 3.750 (1.248–11.272) | .019 | 1.585 (0.424–5.922) | .793 |
| Cancer type | .115 | |||||
| Breast | 33 (10.1) | 86 (26.2) | Ref | |||
| Colorectal | 16 (4.9) | 25 (7.6) | 0.600 (0.285–1.263) | .178 | ||
| Lung | 37 (11.3) | 131 (39.9) | 1.359 (0.790–2.337) | .268 | ||
| Cancer stage | .125 | |||||
| Stage I | 3 (0.9) | 7 (2.1) | Ref | <.001 | .048 | |
| Stage II | 4 (1.2) | 43 (13.1) | 4.607 (0.844–25.137) | .078 | 1.920 (0.287–12.834) | .501 |
| Stage III | 29 (8.8) | 114 (34.8) | 1.685 (0.410–6.919) | .469 | 1.009 (0.209–4.860) | .991 |
| Stage IV | 50 (15.2) | 78 (23.8) | 0.669 (0.165–2.707) | .573 | 0.482 (0.100–2.331) | .364 |
| Duration of cancer(month) | 3.5 (2.6) | 4 (2.9.25) | 0.999 (0.983–1.015) | .888 | ||
Note: Bold p values are statistically significant. (P25, P75) is the interquartile range.
Abbreviations: 95% CI, 95% confidence interval; OR, odds ratio.